- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Gastroenterology Research and Practice
Volume 2010 (2010), Article ID 641865, 11 pages
The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice
1Department of Microbiology, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya 663-8501, Japan
2Department of Surgery, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya 663-8501, Japan
3Department of Immunology & Medical Zooloty, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya 663-8501, Japan
4Cancer Center, Hyogo College of Medicine, Nishinomiya, Japan
Received 11 March 2010; Accepted 22 April 2010
Academic Editor: Ekihiro Seki
Copyright © 2010 Hiroko Tsutsui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Administration of heat-killed Propionibacterium acnes renders mice highly susceptible to LPS. After LPS challenge P. acnes-primed mice promptly show hypothermia, hypercoagulation (disseminated intravascular coagulation), elevation of serum proinflammatory cytokine levels, and high mortality. The surviving mice develop liver injury. As previously reported, IL-18 plays a pivotal role in the development of this liver injury. Many cell types including macrophages constitutively store IL-18 as biologically inactive precursor (pro) form. Upon appropriate stimulation exemplified by TLR4 engagement, the cells secrete biologically active IL-18 by cleaving pro-IL-18 with caspase-1. Caspase-1 is also constitutively produced as a zymogen in macrophages. Recently, NLRP3, a cytoplasmic pathogen sensor, has been demonstrated to be involved in the activation of caspase-1. Here, we review the molecular mechanisms for the liver injuries, particularly focusing on the TLR4/NLRP3-mediated caspase-1 activation process, with a brief introduction of the mechanism underlying P. acnes-induced sensitization to LPS.
TLR, topics of this issue, is an extracellular sensor family of pathogen-associated molecular patterns (PAMPs) [1, 2]. As described by Yamamoto et al. in this special issue, TLR1, TLR2, TLR4, TLR5, TLR6, and TLR11 are expressed on the cell surface, while TLR3, TLR7, TLR8, and TLR9 are expressed on the membrane of endosome, which is a transport vesicle originated from the cell membrane to trap and transport the extracellular macromolecules into the inside of the cells. Besides, mammalian host possess cytoplasmic sensors consisting of at least two families, RIG-I-like receptor (RLR) and Nod-like receptor (NLR) families [3–5]. After sensing intracellular, virus-derived double-stranded (ds) RNA, RLR members relay a signal to activate inflammatory responses for viral clearance via induction of proinflammatory cytokines and type 1 IFNs [6, 7]. Some of the NLR family members are associated with the cytoplasmic formation and activation of inflammasome. Inflammasome is a multiple protein complex and is regarded as the platform for activation of caspase-1 [8, 9]. Caspase-1 is produced as enzymatically inactive precursors (pro) and requires appropriate cleavage to become active. Macrophages including Kupffer cells constitutively produce procaspase-1 and accomplish caspase-1 activation in the inflammasomes after being stimulated [10–12]. Caspase-1 cleaves biologically inactive pro-IL-1 and pro-IL-18, leading to extracellular release of the corresponding active forms. Many cell types including Kupffer cells produce and store pro-IL-18 in the steady state, while they start to produce pro-IL-1 only after activation with appropriate stimuli [13–15]. Thus, the inflammasomes contribute to the secretion of IL-18 and IL-1 via activation of caspase-1.
Inflammasome is composed of certain member of NLR and procaspase 1 [5, 8, 9] (Figure 1). NLR family members are divided into two groups. One is an NLRP group possessing pyrin domain (PYD), and the other is an NLRC group lacking PYD but possessing caspase recruitment domain (CARD) . NLRP1 (Nalp1), NLRP3 (Nalp3), and NLRC4 (Ipaf) have been demonstrated to nucleate the inflammasomes [5, 19]. In the inflammasome these NLRs are believed to sense cytoplasmic PAMPs exemplified by LPS presumably via their leucine rich repeat (LRR) domain. LRR domain of NLRP3 can recognize all of the TLR agonists except for TLR5 agonist, flagellin of bacterial flagellum, while that of NLRC4 senses flagellin . After being stimulated the NLRs are self-oligomerized by binding each other using their nucleotide-binding domain (NBD). Self-oligomerized NLRP1 directly recruits procaspase-1 by homophilic protein-protein interaction between its N-terminal CARD and CARD of procaspase1 and/or procaspase-5 . ASC consisting of PYD and CARD is regarded as an adapter protein for caspase-1 activation. The NLRP1 can bind to PYD of ASC by its PYD domain at C-terminus, and CARD of ASC eventually recruits procaspase-1 by CARD-CARD interaction (Figure 1). The same scenario can be sketched for the recruitment of procaspase-1 around the oligomerized NLRP3-ASC complexes (Figure 1). NLRC4 has CARD but not PYD. Upon appropriate stimulation of NLRC4, procaspase-1 is recruited onto NLRC4 directly by CARD-CARD interaction (Figure 1). Recently, AIM2, belonging to a different protein family namely PYHIN, was reported to activate caspase-1 by sensing cytoplasmic ds-DNA [7, 21–25]. After recognition of ds-DNA by HIN 200 domain of it, AIM2 might be self-oligomerized for recruitment of procaspase-1 by similarly interposing ASC between these two proteins (Figure 1). Recruitment of procaspase-1 into these inflammasomes is likely to activate caspase-1, leading to conversion from pro-IL-18 and pro-IL-1 into active IL-18 and IL-1  (Figure 2).
As previously reported, mice having received heat-killed Propionibacterium acnes are highly susceptible to LPS [27–30]. P. acnes-primed mice suffer from liver injuries after LPS challenge. However, administration of neutralizing anti-IL-18 antibodies (Abs) just before LPS challenge can prevent P. acnes-primed mice from the liver injury . Besides, Il18-/- mice are resistant to the P. acnes/LPS treatment . Thus, IL-18 is important for the development of liver injuries. Here, we review the mechanisms for the P. acnes/LPS-induced liver injuries, particularly focusing on those how active IL-18 is released. Prior to addressing this, we would like to introduce the cellular and molecular mechanisms by which pretreatment with P. acnes render mice highly susceptible to LPS.
2. Endotoxin Shock Syndrome in P. acnes/LPS-Treated Mice
Hypothermia, hypercoagulation (disseminated intravascular coagulation; DIC), high lethality, and tissue injuries are major clinical manifestations of endotoxin shock syndrome [30–35]. After challenge with a subclinical dose of LPS, naïve wild-type (WT) mice do not show these signs (Table 1). In contrast, mice having received heat-killed P. acnes 7 days before are highly susceptible to LPS. P. acnes-primed mice, but not naïve mice, show obvious and gradual reduction of rectal temperature, serum elevation of proinflammatory cytokines including IL-6, IFN-, and TNF-, high mortality and liver injuries after challenge with the same subclinical dose of LPS [18, 30, 32]. LD50 to LPS in P. acnes-primed mice is a thousandth or less of that in naïve mice . Furthermore, they exhibit severe hypercoagulation status, which is monitored by plasma levels of coagulation indicator, thrombin antithrombin complexes (TAT), and anti-fibrinolytic protein, plasminogen activator type 1 (PAI-1) that potently inhibits fibrinolysis by blocking conversion from plasminogen into fibrinolytic plasmin [32, 36]. P. acnes-primed mice, but not naïve mice, tremendously increase plasma levels of TAT and PAI-1 after LPS challenge . Thus, P. acnes treatment powerfully sensitizes mice to LPS.
3. Kupffer Cell Ingestion of Heat-killed P. acnes
P. acnes, a Gram-positive bacterium, is often detectable on human skin and has been believed to be relevant to various inflammatory diseases, such as synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) and sarcoidosis . What happens in mice treated with heat-killed P. acnes? To address this, we labeled heat-killed P. acnes by Cy3, injected them into WT mice through a tail vein, and sampled various tissue specimens at 3 h. We examined tissue distribution of Cy3+ particles by confocal microscopic analyses. Expectedly, heat-killed P. acnes are accumulated in the liver and spleen, whereas they were almost absent in the lung and kidney (Figure 3). F4/80+ cells principally capture P. acnes in the liver, while both F4/80- cells and F4/80+ cells ingest them in the spleen (Figure 3).
At day 7 after P. acnes treatment tremendous hepatosplenomegaly is observed (Figure 4(a)). The liver doubles its normal weight, whereas weight of spleen achieve more than 5 times (Figure 4(b)). In contrast to the liver and spleen, weight of kidney or lung remains unchanged. In the liver, the dense granulomas primarily consisting of F4/80+ macrophages develop, in the center of which P. acnes-ingested F4/80+ Kupffer cells are localized (Figure 4(c)), suggesting that P. acnes-ingested F4/80+ Kupffer cells might recruit many F4/80+ macrophages. Immunostaining using rhodamine-conjugated anti-F4/80 mAb followed by counter-staining with hematoxylin reveals that abundant F4/80+ cells are present in the hepatic granulomas . In contrast to the liver, obvious accumulation of F4/80+ cells around P. acnes is absent in the spleen (Figure 4(c)). Many dendritic cells were reported to compose the hepatic granulomas as well [39, 40]. P. acnes treatment increases hepatic F4/80+ cell number to 30 times and more of that in naïve mice, while the splenic F4/80+ cell number reaches only less than 5 times (Figure 4(d)). Furthermore, splenic macrophages from P. acnes-primed mice produce much higher levels of proinflammatory cytokines including TNF- in response to LPS than do those from naïve mice . This is also the case for Kupffer cells. Thus, P. acnes treatment induces both numerical increase and qualitative alteration of macrophages in the liver and spleen. This may implicate the importance of macrophages for the accomplishment of the LPS sensitization by P. acnes treatment.
4. Requirement of Macrophages for the Sensitization to LPS Induced by P. acnes Treatment
Depletion of macrophages rescues P. acnes-primed mice from the liver injury and high mortality induced by the subsequent challenge with LPS  (Table 1). This clearly demonstrates the indispensability of macrophages for the P. acnes-induced sensitization to LPS. Intravenous injection of clodronate liposome depletes macrophages in mice, while control PBS liposome do not affect them . These two groups of mice are treated with P. acnes, followed by LPS challenge at day 7. The P. acnes-primed mice depleted of macrophages show phenotypes similar to naïve mice after LPS challenge . They lack liver injury and 100% survive (Table 1). P. acnes-primed mice receiving PBS liposome, however, show the susceptibility to LPS similar to that in P. acnes-primed mice . Thus, macrophages are necessarily required for the P. acnes-induced sensitization to LPS.
5. Importance of MyD88-IL-12-IFN- Axis for the Sensitization to LPS
It is well established that IFN- can potently prime macrophages to efficiently respond to LPS . IFN--primed macrophages produce much larger amounts of TNF- and IL-6 than naïve cells . Furthermore, Th1 cell differentiation occurs both in the liver and spleen after P. acnes treatment in a manner dependent on IL-12, a prototype cytokine for Th1 cell differentiation [32, 43]. Splenocytes and splenic T cells from P. acnes-primed WT mice produce a large amount of IFN- but entirely not IL-4 in response to heat-killed P. acnes and immobilized anti-CD3 mAb, respectively [18, 32]. Besides, splenic T cells from P. acnes-primed mice do not differentiate into Th1 cells [18, 44]. Hepatic T cells differentiate toward Th1 cells as well, which is totally inhibited by the treatment with neutralizing anti-IL-12 monoclonal antibody (mAb) . IL-12 directly activates hepatic NK cells to produce IFN- [46, 47]. Furthermore, hepatic NK cells are numerically increased and acquire the high responsiveness to LPS during P. acnes priming phase . From these observations together, one may assume the importance of IL-12-IFN- axis for the development of LPS sensitization via induction of Th1 cells. Expectedly, P. acnes-primed mice, mice or mice with inherited unresponsiveness to IL-12 are resistant to LPS, in terms of lack of hypothermia, hypercoagulation or high mortality [32, 49] (Table 2). In addition, neither nor mice form dense hepatic granulomas after P. acnes treatment [18, 50] (Table 2). Thus, IL-12-IFN- axis is critical for the LPS sensitization.
As they cannot actively enter into inside of cells, heat-killed P. acnes are likely to be recognized by extracellular sensor TLR. As expected, MyD88, which is a key signal adapter molecule of the major TLR signal pathway , is essentially required for the development of hepatic granulomas after P. acnes priming, strongly suggesting critical role of TLR/MyD88 pathway in the development of P. acnes-induced LPS sensitization. mice lack hepatic granuloma formation after P. acnes treatment, and after LPS challenge P. acnes-primed mice do not suffer from the mortality or liver injuries [38, 51] (Table 2, Figure 5). The MyD88-mediated pathway activates nuclear translocation of NF-κB . It is intriguingly to note that administration of NF-κB decoy during P. acnes priming phase completely abrogates the hepatic granuloma formation and the sensitization to LPS in WT mice . This strengthens further the importance of the MyD88-mediated pathway for the LPS sensitization. Among TLR members, TLR9 that senses bacterial unmethylated CpG DNA, but not TLR2 that recognize bacterial cell wall product peptidoglycan, was clearly verified to be required for the LPS sensitization by P. acnes priming [52, 53]. Indeed, P. acnes-primed mice are comparably susceptible to LPS as P. acnes-primed WT mice, although P. acnes possess abundant TLR2 ligands in their cell walls (52). In contrast, P. acnes-primed mice, like mice, fail to develop hepatic granulomas and become susceptible to LPS . This suggests that unmethylated CpG-DNA of P. acnes is pivotal for the sensitization to LPS at least by P. acnes-priming. Taken together, these observations strongly suggest that the MyD88-IL-12-IFN- axis plays a pivotal role in the hepatic granuloma formation and sensitization to LPS (Figure 5).
Upon challenge with TNF- instead of LPS, P. acnes-primed WT mice show the manifestations/signs similar to those of endotoxin shock syndrome [29, 30, 32], indicating that TNF- is an effector cytokine and that P. acnes treatment tremendously facilitates responsiveness to TNF-. TNF--challenged, P. acnes-primed mice, but not naïve mice, suffer from hypothermia with exceptionally high plasma levels of plasma TAT and PAI-1 and show high mortality. Consistently, P. acnes-primed mice are resistant to TNF- as well . Thus, P. acnes treatment renders mice highly susceptible to LPS for TNF- production and also to TNF- itself via induction of IFN- production.
6. Importance of IFN- for the Systemic Endotoxin Shock Manifestations after LPS Challenge
Administration of neutralizing anti-IFN- mAb just before LPS challenge could partly rescue P. acnes-primed mice from hypothermia, hypercoagulation, and high mortality , demonstrating the importance of endogenous IFN- for the accomplishment of LPS phase as well. Taken together, IFN- is a master regulator of the systemic endotoxin shock syndrome by induction of the sensitization to LPS and activation of the LPS phase.
7. IL-18 Is Necessary and Sufficient for the Development of Liver Injuries
Upon LPS challenge many P. acnes-primed WT mice shortly died, and the surviving mice suffer from liver injuries later (Figure 6). Blockade of IL-18 or genetic depletion of Il18 can protect against the liver damages [17, 54] (Figure 6). Upon LPS challenge P. acnes-primed mice having normally dense hepatic granulomas develop the endotoxin shock syndrome comparably as P. acnes-primed WT mice . In contrast, the surviving mice evade the liver injuries  (Figure 6). These results indicate that IL-18 is necessary for the development of this liver injury. Furthermore, administration of IL-18 causes liver injuries in P. acnes-primed WT mice but not naïve mice . Therefore, IL-18 is necessary and sufficient for P. acnes/LPS-induced liver injury.
IL-18 is capable of inducing hepatocytotoxic TNF- directly in many cell types . NK cells and Th1 cells, but not naïve T cells, express IL-18R [47, 56]. During P. acnes priming phase, naïve T cells differentiate into P. acnes-specific Th1 cells as described above. Therefore, IL-18 activates both NK cells and P. acnes-specific Th1 cells to produce robust IFN-, which in turn might fully activate Kupffer cells and hepatic macrophages to further produce TNF- . In addition, IL-18 has potent capacity to induce and upregulate Fas ligand expression on NK cells enough to kill Fas-expressing hepatocytes . Thus, endogenous IL-18 participates in the liver injuries through induction of proinflammatory cytokines and cell death-inducing protein.
8. Kupffer Cells Secrete IL-18 in a Manner Dependent on TRIF and the NLRP3 Inflammasome
Many investigators use peritoneal exudate cells (PEC) prepared from the mice administered intraperitoneally with thioglycorate or bone marrow-derived macrophages (BMM) by incubation of bone marrow cells with recombinant monocyte colony-stimulating factor as conventional murine macrophages. These two types of macrophages cannot secrete IL-1 or IL-18 after stimulation with LPS alone. However, LPS-primed PEC or BMM can secrete robust IL-1 and IL-18 upon subsequent stimulation with exogenous ATP in a TLR4- and caspase-1-dependent fashion [57, 58]. From these observations the following possibilities have been believed. First, TLR4-mediated signal pathway cannot activate caspase-1. Second, ATP signaling via its cell surface receptor is a central event required for the caspase-1 activation in LPS-stimulated macrophages. Third, the TLR4-mediated signal pathway is only required for induction of proIL-1 production. We also confirmed the absence of IL-1 or IL-18 release from LPS-activated PEC or BMM. In contrast to these PEC and BMM, WT Kupffer cells can release substantial amounts of IL-1 and IL-18 in response to LPS or synthetic lipid A (active center of LPS) alone [15, 38, 54, 59] (Table 3), strongly suggesting involvement of the TLR4 signaling in release of IL-1 and IL-18. As LPS-stimulated caspase-1-deficient Kupffer cells do not secrete IL-1 or IL-18 [11, 12], caspase-1 is an essential processing enzyme of such IL-1 and IL-18. In fact, western blotting analyses reveal active form of caspase-1 in the lipid A-stimulated WT Kupffer cells  (Table 3). Expectedly, Kupffer cells fail to activate caspase-1 upon stimulation with lipid A . Thus, Kupffer cells seem to be different from PEC or BMM in the ability to activate caspase-1 upon TLR4 engagement. However, it is still to be elucidated how Kupffer cells acquire the potential to activate caspase-1 in response to TLR4 agonists alone.
The TLR4 signaling is relayed by the MyD88- and TRIF-mediated pathways . Kupffer cells stimulated with TLR4 agonists show normal caspase-1 activation . As the Kupffer cells cannot produce pro-IL-1, eventually resulting in lack of mature IL-1 secretion  (Table 3). In contrast to proIL-1, pro-IL-18 is constitutively stored in Kupffer cells as well as WT cells . Therefore, it is convincing that Kupffer cells cultured with LPS can secrete IL-18 [15, 38] (Table 3). Kupffer cells show the reverse phenomena. Despite of their normal production of pro-IL-1 and pro-IL-18, Kupffer cells cannot release IL-1 or IL-18 due to their inability to activate caspase-1 . These results demonstrate a pivotal role of TRIF but not MyD88 in the TLR4-mediated caspase-1 activation (Table 3, Figure 7).
Kupffer cells have the phenotype similar to cells [38, 60], suggesting that NLRP3 or AIM2 inflammasome or unidentified one that needs ASC protein (Figure 1) is involved in the caspase-1 activation. Lipid A-stimulated Kupffer cells fail to secrete IL-18 or IL-1 . Therefore, the NLRP3 inflammasome activation is necessary for the TLR4-mediated casapse-1 activation (Table 3, Figure 7).
These results cannot exclude the possibility that the TRIF-mediated pathway might cause extracellular release of ATP and that this self-derived ATP might activate the NLRP3 inflammasome in LPS-stimulated Kupffer cells [57, 58]. Unexpectedly, Kupffer cells show normal caspase-1 activation and normal release of IL-1 and IL-18 . These results demonstrate the dispensability of endogenous -mediated pathway for the -mediated caspase-1 activation (Table 3, Figure 7).
Although we now know the importance of the NLRP3 inflammasome, the precise mechanisms by which the TRIF-mediated signal pathway activates the NLRP3 inflammasome is unclear. It is also unknown whether NLRP3 protein directly recognizes TLR4 agonists. If so, how do the TLR4 agonists translocate into the inside of Kupffer cells? Alternatively, does TRIF-mediated pathway trigger synthesis of cytoplasmic NLRP3 agonist? If so, what is the NLRP3 agonist? And, how about the molecular mechanisms for the TRIF-induced NLRP3 agonist? We need further extensive studies to address these key queries.
9. Requirement of NLRP3 Inflammasome Activation for the Liver Injury
The capacity to activate caspase-1 reflects on the development of liver injury [38, 60]. Expectedly, P. acnes-primed mice, although manifesting normal levels of hepatic granuloma formation, can avoid the liver injury after LPS challenge accompanied by lack of serum elevation of IL-18 (Table 3, Figure 7). Since they fail to develop hepatic granulomas, P. acnes-primed mice lack the production of robust IL-18 after P. acnes priming, presumably resulting in escape from the liver injury (Table 3, Figure 7). This demonstrates again requirement of MyD88 for the P. acnes-induced LPS sensitization. Conversely, P. acnes-primed mice, mice, mice and mice all have normal dense granulomas in their livers, but fail to develop liver injury after LPS challenge, concomitant with the absence of the serum IL-18 increase (Table 3, Figure 7). mice have comparable phenotype as WT mice (Table 3, Figure 7), demonstrating dispensability of endogenous pathway for the liver injuries. Thus, the -mediated activation of NLRP3 inflammasome is critical for the development of the P. acnes/LPS-induced liver injuries via activation of caspase-1 for maturation and release of IL-18.
C57BL/6 mice were purchased from Clea Japan (Osaka, Japan). Female mice (8–12-week-old) were used for this study. Mice were maintained under specific pathogen-free conditions, and received humane care as outlined in the Guide for the Care and Use of Experimental Animals in Hyogo College of Medicine.
Monoclonal antibody (mA) against F4/80 of mouse macrophage was purchased from BMA (Augst, Switzerland). DAPI was from KPL (Gaitherburg, MD).
10.3. Treatment with P. acnes
Heat-killed P. acnes were labeled with or without Cy3 (GE, Buchinghamshire, UK) according to the manufacture’s instruction and were injected into mice through a tail vein. At the indicated time points various tissues and tissue specimens were sampled for weighing and analysis of the cellularity by confocal microscopy, respectively.
10.4. Confocal Microscopic Analysis
Frozen sections of various tissues were incubated with mAb against F4/80, biotinylated antirat IgG, and then Alexa Fluor 488-conjugated streptavidin (Molecular Probes). Nuclei were stained by DAPI. The immunostaining of each section was evaluated using a laser scanning confocal microscopy [61, 62].
10.5. Flowcytometry 
Spleen cells and Kupffer cells were isolated from variously treated WT B6 mice . Cells were incubated with APC-conjugated anti-F4/80 mAb.
11. Closing Remarks
PAMPs evoke innate immune responses by activating pattern recognition receptors (PRRs), such as TLR, NLR, and RLR. Similarly, injured host cells release endogenous “damage”-associated molecular patterns (DAMPs) that induce similar responses via recognition by PRRs [63–65]. For example, high-mobility group box1 protein (HMGB1) that is localized in the nuclei of various cell types in the steady state becomes to be extracellularly released upon stimulation of the cells with death stress. HMGB1, then, initiates innate immune responses via activating TLR4 . Mitochondria are endosymbionts derived from certain bacteria during the evolution of life. Therefore, it is plausible that mitochondria possess DAMPs homologous to its ancestral PAMPs. Very recently, this was verified . Mitochondrion possesses unmethylated CpG-DNA and formyl peptides similar to bacterial N-formylated proteins, which are recognized by PRRs expressed on neutrophils, TLR9, and formyl peptide receptor, respectively. Intravenous injection of the mitochondrial DAMPs causes systemic inflammatory responses and lung injuries . As trauma patients have elevated serum levels of these mitochondrial DAMPs, sterile injury-induced systemic inflammatory response syndrome (SIRS), often occurring after severe trauma, might undergo in response to endogenous mitochondrial DAMPs derived from the injured cells . In addition to DAMPs, self-derived “alarmin” is proposed as another potent inflaming molecules. “Alarmin” is compartmentalized in certain organelle in the steady state. Once damaged, cells begin to actively secrete “alarmin”, which in turn triggers inflammatory responses. Intraperitoneal injection of dying cells was reported to be able to trigger peritonitis with dense neutrophil recruitment in an IL-1/IL-1R-dependent manner . Furthermore, administration of acetoaminophen, a common antipyretic, causes massive liver injury with sterile neutrophilic inflammation in a manner dependent on IL-1 presumably derived from the damaged hepatocytes as well . Thus, dying cell-derived IL-1 is regarded as alarmin. Like IL-1, IL-33 is localized in the cell nuclei in the steady state and is believed to be secreted after stimulation of the cells with death stress . Histone proteins derived from cell nuclei play a role as alarmin as well . These endogenous DAMPs and alarmin might accelerate liver injuries induced by exogenous PAMPs and might become novel therapeutic targets for severe sepsis with organ failures.
This work was supported in part by a Hitec Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Grants from the Naito Foundation and the Japanese Foundation for Applied Enzymology. The authors would like to thank Ms Mitani for an excellent technique.
- C. A. Janeway Jr. and R. Medzhitov, “Innate immune recognition,” Annual Review of Immunology, vol. 20, pp. 197–216, 2002.
- S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006.
- A. Komuro, D. Bamming, and C. M. Horvath, “Negative regulation of cytoplasmic RNA-mediated antiviral signaling,” Cytokine, vol. 43, no. 3, pp. 350–358, 2008.
- M. S. Lee and Y.-J. Kim, “Signaling pathways downstream of pattern-recognition receptors and their cross talk,” Annual Review of Biochemistry, vol. 76, pp. 447–480, 2007.
- A. Stutz, D. T. Golenbock, and E. Latz, “Inflammasomes: too big to miss,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3502–3511, 2009.
- S.-Y. Zhang, S. Boisson-Dupuis, and S. Boisson-Dupuis, “Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense,” Immunological Reviews, vol. 226, no. 1, pp. 29–40, 2008.
- V. Hornung and E. Latz, “Intracellular DNA recognition,” Nature Reviews Immunology, vol. 10, no. 2, pp. 123–130, 2010.
- F. Martinon, K. Burns, and J. Tschopp, “The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002.
- J. Tschopp, F. Martinon, and K. Burns, “NALPs: a novel protein family involved in inflammation,” Nature Reviews, vol. 4, no. 2, pp. 95–104, 2003.
- K. Kuida, J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S.-S. Su, and R. A. Flavell, “Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme,” Science, vol. 267, no. 5206, pp. 2000–2003, 1995.
- Y. Gu, K. Kuida, and K. Kuida, “Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme,” Science, vol. 275, no. 5297, pp. 206–209, 1997.
- T. Ghayur, S. Banerjee, and S. Banerjee, “Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production,” Nature, vol. 386, no. 6625, pp. 619–623, 1997.
- K. Nakanishi, T. Yoshimoto, H. Tsutsui, and H. Okamura, “Interleukin-18 regulates both Th1 and Th2 responses,” Annual Review of Immunology, vol. 19, pp. 423–474, 2001.
- H. Tsutsui, T. Yoshimoto, N. Hayashi, H. Mizutani, and K. Nakanishi, “Induction of allergic inflammation by interleukin-18 in experimental animal models,” Immunological Reviews, vol. 202, pp. 115–138, 2004.
- E. Seki, H. Tsutsui, and H. Tsutsui, “Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β,” Journal of Immunology, vol. 166, no. 4, pp. 2651–2657, 2001.
- I. Ogushi, Y. Iimuro, and Y. Iimuro, “Nuclear factor κB decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model,” Hepatology, vol. 38, no. 2, pp. 335–344, 2003.
- H. Okamura, H. Tsutsui, and H. Tsutsui, “Cloning of a new cytokine that induces IFN-γ production by T cells,” Nature, vol. 378, no. 6552, pp. 88–91, 1995.
- Y. Sakao, K. Takeda, and K. Takeda, “IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock,” International Immunology, vol. 11, no. 3, pp. 471–480, 1999.
- J. P.-Y. Ting, R. C. Lovering, and R. C. Lovering, “The NLR gene family: a standard nomenclature,” Immunity, vol. 28, no. 3, pp. 285–287, 2008.
- T.-D. Kanneganti, M. Lamkanfi, and M. Lamkanfi, “Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling,” Immunity, vol. 26, no. 4, pp. 433–443, 2007.
- D. A. Muruve, V. Pétrilli, and V. Pétrilli, “The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response,” Nature, vol. 452, no. 7183, pp. 103–107, 2008.
- V. Hornung, A. Ablasser, and A. Ablasser, “AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC,” Nature, vol. 458, no. 7237, pp. 514–518, 2009.
- T. Fernandes-Alnemri, J.-W. Yu, P. Datta, J. Wu, and E. S. Alnemri, “AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA,” Nature, vol. 458, no. 7237, pp. 509–513, 2009.
- T. Bürckstümmer, C. Baumann, and C. Baumann, “An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome,” Nature Immunology, vol. 10, no. 3, pp. 266–272, 2009.
- T. L. Roberts, A. Idris, and A. Idris, “HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA,” Science, vol. 323, no. 5917, pp. 1057–1060, 2009.
- F. Martinon, A. Mayor, and J. Tschopp, “The inflammasomes: guardians of the body,” Annual Review of Immunology, vol. 27, pp. 229–265, 2009.
- J. Ferluga and A. C. Allison, “Role of mononuclear infiltrating cells in pathogenesis of hepatitis,” The Lancet, vol. 1, no. 8090, pp. 610–611, 1978.
- Y. Mizoguchi, H. Tsutsui, and H. Tsutsui, “The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model,” Hepatology, vol. 7, no. 6, pp. 1184–1188, 1987.
- H. Tsutsui, Y. Mizoguchi, and S. Morisawa, “Importance of direct hepatocytolysis by liver macrophages in experimental fulminant hepatitis,” Hepato-Gastroenterology, vol. 39, no. 6, pp. 553–559, 1992.
- T. Yoshimoto, K. Nakanishi, and K. Nakanishi, “High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor,” Journal of Immunology, vol. 148, no. 11, pp. 3596–3603, 1992.
- J. A. Russell, “Management of sepsis,” The New England Journal of Medicine, vol. 355, no. 16, pp. 1699–1713, 2006.
- K. Kawa, H. Tsutsui, and H. Tsutsui, “IFN-γ is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes,” International Immunology, vol. 22, no. 3, pp. 157–166, 2010.
- T. P. Clemmer, C. J. Fisher Jr., and C. J. Fisher Jr., “Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group,” Critical Care Medicine, vol. 20, no. 10, pp. 1395–1401, 1992.
- D. G. Remick and H. Xioa, “Hypothermia and sepsis,” Frontiers in Bioscience, vol. 11, no. 1, pp. 1006–1013, 2006.
- M. Levi and H. Ten Cate, “Disseminated intravascular coagulation,” The New England Journal of Medicine, vol. 341, no. 8, pp. 586–592, 1999.
- M. S. Sawdey and D. J. Loskutoff, “Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β,” Journal of Clinical Investigation, vol. 88, no. 4, pp. 1346–1353, 1991.
- L. Romics Jr., A. Dolganiuc, and A. Dolganiuc, “Selective priming to toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice,” Hepatology, vol. 40, no. 3, pp. 555–564, 2004.
- M. Imamura, H. Tsutsui, and H. Tsutsui, “Contribution of TIR domain-containing adapter inducing IFN-β-mediated IL-18 release to LPS-induced liver injury in mice,” Journal of Hepatology, vol. 51, no. 2, pp. 333–341, 2009.
- H. Yoneyama, K. Matsuno, and K. Matsuno, “Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease,” Journal of Experimental Medicine, vol. 193, no. 1, pp. 35–49, 2001.
- H. Yoneyama, S. Narumi, and S. Narumi, “Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes,” Journal of Experimental Medicine, vol. 195, no. 10, pp. 1257–1266, 2002.
- N. Van Rooijen and A. Sanders, “Elimination, blocking, and activation of macrophages: three of a kind?” Journal of Leukocyte Biology, vol. 62, no. 6, pp. 702–709, 1997.
- M. A. Collart, D. Belin, J.-D. Vassalli, S. de Kossodo, and P. Vassalli, “γ interferon enhances macrophages transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors,” Journal of Experimental Medicine, vol. 164, no. 6, pp. 2113–2118, 1986.
- K. Takeda, H. Tsutsui, and H. Tsutsui, “Defective NK cell activity and Th1 response in IL-18-deficient mice,” Immunity, vol. 8, no. 3, pp. 383–390, 1998.
- A. Kumanogoh, T. Shikina, and T. Shikina, “Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice,” Immunity, vol. 22, no. 3, pp. 305–316, 2005.
- K. Matsui, T. Yoshimoto, and T. Yoshimoto, “Propionibacterium acnes treatment diminishes T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells,” Journal of Immunology, vol. 159, no. 1, pp. 97–106, 1997.
- G. Trinchieri, “Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity,” Annual Review of Immunology, vol. 13, pp. 251–276, 1995.
- Y. Hyodo, K. Matsui, and K. Matsui, “IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor,” Journal of Immunology, vol. 162, no. 3, pp. 1662–1668, 1999.
- J. Sawaki, H. Tsutsui, N. Hayashi, K. Yasuda, S. Akira, T. Tanizawa, and K. Nakanishi, “Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways,” International Immunology, vol. 19, no. 3, pp. 311–320, 2007.
- T. Merlin, A. Sing, P. J. Nielsen, C. Galanos, and M. A. Freudenberg, “Inherited IL-12 unresponsiveness contributes to the high LPS resistance of the C57BL/10ScCr mouse,” Journal of Immunology, vol. 166, no. 1, pp. 566–573, 2001.
- H. Tsuji, N. Mukaida, and N. Mukaida, “Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium aches-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production,” Journal of Immunology, vol. 162, no. 2, pp. 1049–1055, 1999.
- I. Hritz, A. Velayudham, A. Dolganiuc, K. Kodys, P. Mandrekar, E. Kurt-Jones, and G. Szabo, “Bone Marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion,” Hepatology, vol. 48, no. 4, pp. 1342–1347, 2008.
- L. Romics Jr., A. Dolganiuc, and A. Dolganiuc, “Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propionibacterium acnes,” Journal of Leukocyte Biology, vol. 78, no. 6, pp. 1255–1264, 2005.
- C. Kalis, M. Gumenscheimer, and M. Gumenscheimer, “Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes,” Journal of Immunology, vol. 174, no. 7, pp. 4295–4300, 2005.
- H. Tsutsui, K. Matsui, and K. Matsui, “IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice,” Journal of Immunology, vol. 159, no. 8, pp. 3961–3967, 1997.
- H. Tsutsui, N. Kayagaki, and N. Kayagaki, “Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice,” Immunity, vol. 11, no. 3, pp. 359–367, 1999.
- T. Yoshimoto, K. Takeda, and K. Takeda, “IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production,” Journal of Immunology, vol. 161, no. 7, pp. 3400–3407, 1998.
- S. Mariathasan and D. M. Monack, “Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation,” Nature Reviews Immunology, vol. 7, no. 1, pp. 31–40, 2007.
- F. Martinon and J. Tschopp, “Inflammatory caspases and inflammasomes: master switches of inflammation,” Cell Death and Differentiation, vol. 14, no. 1, pp. 10–22, 2007.
- K. Matsui, H. Tsutsui, and K. Nakanishi, “Pathophysiological roles for IL-18 in inflammatory arthritis,” Expert Opinion on Therapeutic Targets, vol. 7, no. 6, pp. 701–724, 2003.
- M. Yamamoto, K. Yaginuma, and K. Yaginuma, “ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules,” Genes to Cells, vol. 9, no. 11, pp. 1055–1067, 2004.
- M. Terada, H. Tsutsui, and H. Tsutsui, “Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 23, pp. 8816–8821, 2006.
- E. Seki, Y. Kondo, and Y. Kondo, “Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings,” Journal of Hepatology, vol. 48, no. 2, pp. 237–245, 2008.
- P. Matzinger, “The danger model: a renewed sense of self,” Science, vol. 296, no. 5566, pp. 301–305, 2002.
- A. Rubartelli and M. T. Lotze, “Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox,” Trends in Immunology, vol. 28, no. 10, pp. 429–436, 2007.
- M. T. Lotze, H. J. Zeh, and H. J. Zeh, “The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity,” Immunological Reviews, vol. 220, no. 1, pp. 60–81, 2007.
- M. T. Lotze and K. J. Tracey, “High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal,” Nature Reviews Immunology, vol. 5, no. 4, pp. 331–342, 2005.
- Q. Zhang, M. Raoof, and M. Raoof, “Circulating mitochondrial DAMPs cause inflammatory responses to injury,” Nature, vol. 464, no. 1, pp. 104–107, 2010.
- C.-J. Chen, H. Kono, D. Golenbock, G. Reed, S. Akira, and K. L. Rock, “Identification of a key pathway required for the sterile inflammatory response triggered by dying cells,” Nature Medicine, vol. 13, no. 7, pp. 851–856, 2007.
- G. Haraldsen, J. Balogh, J. Pollheimer, J. Sponheim, and A. M. Küchler, “Interleukin-33-cytokine of dual function or novel alarmin?” Trends in Immunology, vol. 30, no. 5, pp. 227–233, 2009.
- J. Xu, X. Zhang, and X. Zhang, “Extracellular histones are major mediators of death in sepsis,” Nature Medicine, vol. 15, no. 11, pp. 1318–1321, 2009.